Ocular tissues and fluids oxidative stress in hares fed on verbascoside supplement.

The influence of a prolonged diet supplemented with the powerful antioxidant verbascoside on the oxidative state of 20 healthy hares eye fluids and tissues has been studied. Verbascoside was dosed at 2, 3, 4 mg/die and the impact on the oxidative state of ocular tissues and fluids was tested by TBARS (thio barbituric acid reactive substances) and TEAC (trolox equivalent antioxidant capacity) assays. The percentage of change in antioxidant activity increased largely in retina and lenses at a daily verbascoside dose of 3 mg, whereas for optic nerve and vitreous humor the higher antioxidant capacity was measured at 4 mg/die verbascoside dose. The present findings demonstrate that verbascoside supplementation is able to protect ocular tissue and fluids from naturally occurring oxidation and that its protective effect depends on the daily dose, being maximum up to 3 mg/die.

Effects of verbascoside-based diet on blood and plasma constituents of rabbits.

OBJECTIVE: Oxidative stress brought on by free radicals can lead to an increased risk of some chronic pathologies. Antioxidants can scavenge free radicals by turning them into nonradical and nontoxic metabolites. The purpose of this study is to investigate the effect of a phenylpropanoid glycosides-based prolonged diet on blood constituents in animals. METHODS: Tests were carried out on healthy New Zealand white rabbits and the following parameters were evaluated at baseline and after 90 days' follow-up: plasma triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, aspartate transaminase, alanine aminotransferase, bilirubin, the reactive oxygen metabolites, thiobarbituric acid-reactive substances, vitamin A, and vitamin E. The same parameters were analyzed in an age- and sex-matched animal control group. RESULTS: We first defined the concept of average rate and then used it to calculate, by experimental data fitting, the formation or destruction rate of some blood or plasma constituents as a function of the daily dose. The results indicate that the effects can be categorized into 2 classes. The first includes the effects that produce monotonously continuous changes with daily dose, and the second includes those that exhibit a saturating trend. CONCLUSIONS: The experimental results suggest that high doses of verbascoside can potentially cause adverse effects through prooxidative effects. Risk is increased by the use of pharmacological doses of polyphenols in prevention, treatment, and as dietary supplements.

Lipid oxidation in water-in-olive oil emulsions initiated by a lipophilic radical source.

The lipophilic 2,2'-azobis(2,4-dimethylvaleronitrile) (AMVN) was used to study thoroughly the oxidation reaction in a model water-in-olive oil emulsion system. This radical species decomposes thermally generating a constant flux of radicals in the oil phase. The dissociation constant k(d) in olive oil at 40 degrees C for AMVN was calculated as 2.5 x 10(-4) min(-1) and the rate of initiation of the oxidation reaction, R(i) was calculated by using vitamin E as antioxidant. The olive oil oxidation in emulsion was monitored by measuring the hydroperoxide concentration by a sensitive fluorimetric method. The DPPP (diphenyl-1-pyrenylphosphine) was used as a probe because it reacts stoichiometrically with hydroperoxides to yield a fluorescent product, the diphenyl-1-pyrenylphosphine oxide (DPPP-O). Oxidation data together with emulsion droplet size data showed that in the presence of radical initiator and a large interface, the oxidation reaction is accelerated in W/Olive oil emulsion with respect to whole oil. The mediation of the surface area of water droplets is surely involved in this process because the addition of saturated solutions of ascorbic acid (AA) dispersed in the oil brings about the strong reduction of the oxidation rate even in the presence of the highest AMVN quantity.

The FU gene and its possible protein isoforms.

BACKGROUND: FU is the human homologue of the Drosophila gene fused whose product fused is a positive regulator of the transcription factor Cubitus interruptus (Ci). Thus, FU may act as a regulator of the human counterparts of Ci, the GLI transcription factors. Since Ci and GLI are targets of Hedgehog signaling in development and morphogenesis, it is expected that FU plays an important role in Sonic, Desert and/or Indian Hedgehog induced cellular signaling. RESULTS: The FU gene was identified on chromosome 2q35 at 217.56 Mb and its exon-intron organization determined. The human developmental disorder Syndactyly type 1 (SD1) maps to this region on chromosome 2 and the FU coding region was sequenced using genomic DNA from an affected individual in a linked family. While no FU mutations were found, three single nucleotide polymorphisms were identified. The expression pattern of FU was thoroughly investigated and all examined tissues express FU. It is also clear that different tissues express transcripts of different sizes and some tissues express more than one transcript. By means of nested PCR of specific regions in RT/PCR generated cDNA, it was possible to verify two alternative splicing events. This also suggests the existence of at least two additional protein isoforms besides the FU protein that has previously been described. This long FU and a much shorter isoform were compared for the ability to regulate GLI1 and GLI2. None of the FU isoforms showed any effects on GLI1 induced transcription but the long form can enhance GLI2 activity. Apparently FU did not have any effect on SUFU induced inhibition of GLI. CONCLUSIONS: The FU gene and its genomic structure was identified. FU is a candidate gene for SD1, but we have not identified a pathogenic mutation in the FU coding region in a family with SD1. The sequence information and expression analyses show that transcripts of different sizes are expressed and subjected to alternative splicing. Thus, mRNAs may contain different 5'UTRs and encode different protein isoforms. Furthermore, FU is able to enhance the activity of GLI2 but not of GLI1, implicating FU in some aspects of Hedgehog signaling.

Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs.

Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.